JP2019501116A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501116A5
JP2019501116A5 JP2018522990A JP2018522990A JP2019501116A5 JP 2019501116 A5 JP2019501116 A5 JP 2019501116A5 JP 2018522990 A JP2018522990 A JP 2018522990A JP 2018522990 A JP2018522990 A JP 2018522990A JP 2019501116 A5 JP2019501116 A5 JP 2019501116A5
Authority
JP
Japan
Prior art keywords
wetting
gibinostat
aqueous vehicle
hydration process
intimate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018522990A
Other languages
English (en)
Japanese (ja)
Other versions
JP6800970B2 (ja
JP2019501116A (ja
Filing date
Publication date
Priority claimed from ITUB2015A005193A external-priority patent/ITUB20155193A1/it
Application filed filed Critical
Publication of JP2019501116A publication Critical patent/JP2019501116A/ja
Publication of JP2019501116A5 publication Critical patent/JP2019501116A5/ja
Application granted granted Critical
Publication of JP6800970B2 publication Critical patent/JP6800970B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018522990A 2015-11-03 2016-10-28 物理的および化学的に安定なギビノスタットの経口懸濁液 Active JP6800970B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUB2015A005193A ITUB20155193A1 (it) 2015-11-03 2015-11-03 Sospensioni orali di Givinostat fisicamente e chimicamente stabili
IT102015000068150 2015-11-03
PCT/IB2016/056496 WO2017077436A1 (en) 2015-11-03 2016-10-28 Physically and chemically stable oral suspensions of givinostat

Publications (3)

Publication Number Publication Date
JP2019501116A JP2019501116A (ja) 2019-01-17
JP2019501116A5 true JP2019501116A5 (https=) 2019-06-27
JP6800970B2 JP6800970B2 (ja) 2020-12-16

Family

ID=55410062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018522990A Active JP6800970B2 (ja) 2015-11-03 2016-10-28 物理的および化学的に安定なギビノスタットの経口懸濁液

Country Status (33)

Country Link
US (1) US10688047B2 (https=)
EP (1) EP3370697B1 (https=)
JP (1) JP6800970B2 (https=)
KR (1) KR102603894B1 (https=)
CN (2) CN108366956B (https=)
AR (1) AR106559A1 (https=)
AU (1) AU2016349169B2 (https=)
BR (1) BR122024001653A2 (https=)
CA (1) CA3002755C (https=)
CL (1) CL2018001151A1 (https=)
CO (1) CO2018003971A2 (https=)
CY (1) CY1124092T1 (https=)
DK (1) DK3370697T3 (https=)
ES (1) ES2870201T3 (https=)
FI (1) FIC20250035I1 (https=)
FR (1) FR25C1051I1 (https=)
HR (1) HRP20210747T1 (https=)
HU (2) HUE054123T2 (https=)
IL (1) IL258608B (https=)
IT (1) ITUB20155193A1 (https=)
LT (2) LT3370697T (https=)
MX (1) MX380361B (https=)
NO (1) NO2025053I1 (https=)
NZ (1) NZ741467A (https=)
PE (1) PE20181369A1 (https=)
PL (1) PL3370697T3 (https=)
PT (1) PT3370697T (https=)
RS (1) RS61694B1 (https=)
RU (1) RU2721396C2 (https=)
SI (1) SI3370697T1 (https=)
SM (1) SMT202100161T1 (https=)
TW (1) TWI727983B (https=)
WO (1) WO2017077436A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2567093A (en) 2016-07-15 2019-04-03 Viracta Therapeutics Inc Histone deacetylase inhibitors for use in immunotherapy
IT201900003281A1 (it) * 2019-03-06 2020-09-06 Chemi Spa Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza
CA3142142A1 (en) 2019-05-31 2020-12-03 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors
WO2022088037A1 (zh) * 2020-10-30 2022-05-05 中国科学院深圳先进技术研究院 Sirtinol在制备预防和治疗冠状病毒的药物中的应用
CN114306311A (zh) * 2022-01-14 2022-04-12 同济大学 组蛋白去乙酰化酶抑制剂在制备治疗心脏病的药物中的应用
CN116173003A (zh) * 2023-02-24 2023-05-30 山西医科大学 药物吉维司他在治疗阿尔茨海默病中的用途
WO2026052723A1 (en) 2024-09-05 2026-03-12 Italfarmaco S.P.A. Givinostat hydrochloride monohydrate for use in treating muscular dystrophy

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169150A (en) * 1975-11-12 1979-09-25 Teijin Limited Benzodiazepine derivatives and pharmaceutical compositions containing said derivatives
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
IT1283637B1 (it) 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
US6174905B1 (en) 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
CA2423744C (en) 2000-09-29 2012-04-03 Prolifix Limited Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
AU2002364146A1 (en) * 2001-12-20 2003-07-09 Pharmacia Corporation Pharmaceutical suspension for oral administration
ES2306859T3 (es) 2002-03-13 2008-11-16 Janssen Pharmaceutica Nv Derivados de sulfonil como nuevos inhibidores de histona deacetilasa.
ITMI20030063A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
US7244751B2 (en) 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
SI1611088T1 (sl) 2003-04-07 2009-12-31 Pharmacyclics Inc Hidroksamati kot terapevtska sredstva
DE602004004665T2 (de) 2003-08-20 2008-01-03 Pharmacyclics, Inc., Sunnyvale Acetylenderivate als inhibitoren von histondeacetylase
ITMI20041347A1 (it) 2004-07-05 2004-10-05 Italfarmaco Spa Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
US8193205B2 (en) 2004-07-28 2012-06-05 Janssen Pharmaceutica N.V. Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
WO2006018814A2 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Oral liquid suspensions of metaxalone
CA2645205C (en) * 2006-05-19 2012-12-04 Norbrook Laboratories Limited Stable aqueous suspension having palatable taste
EP2061772A4 (en) 2006-09-11 2011-06-29 Curis Inc MULTIFUNCTIONAL SMALL MOLECULES AS PROLIFERATION-ACTIVE ACTIVE SUBSTANCES
US8263652B2 (en) * 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
EP2228054A1 (en) * 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
MX2012005083A (es) * 2009-10-30 2012-09-28 Janssen Pharmaceutica Nv Regimen de dosificacion asociado con esteres de paliperidona inyetables de accion prolongada.
IT1397912B1 (it) * 2010-01-28 2013-02-04 Chemi Spa Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
US20110245154A1 (en) * 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
TW201245115A (en) * 2011-01-24 2012-11-16 Chdi Foundation Inc Histone deacetylase inhibitors and compositions and methods of use thereof
CN107007580A (zh) * 2012-02-03 2017-08-04 意大发马克股份公司 用于治疗肌肉萎缩症的化合物
WO2014165226A2 (en) * 2013-03-12 2014-10-09 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
EP2968233A4 (en) * 2013-03-14 2016-08-03 Chdi Foundation Inc HISTON DEACETYLASE HEMMER AND COMPOSITIONS AND METHOD FOR USE THEREOF
WO2015086738A2 (en) 2013-12-11 2015-06-18 Bionor Immuno As Hiv vaccine

Similar Documents

Publication Publication Date Title
JP2019501116A5 (https=)
JP2017186574A5 (https=)
Bercea et al. Temperature responsive gels based on Pluronic F127 and poly (vinyl alcohol)
CN103415536B (zh) 具有改进的分散性能的水溶性聚合物粉末配制物
JP2009526026A5 (https=)
RU2014103279A (ru) Самоочищающаяся антисмоговая противоплесневая фотокаталитическая порошкообразная водоразбавляемая краска
JP2010536747A (ja) ピルフェニドンを含有するゲル
CN104001205B (zh) 一种流体敷料及其制备方法
CN105463482A (zh) 一种铝材表面除灰剂及其制备方法和进行表面除灰的方法
CN104902873A (zh) 溶解性差的活性成分的薄膜剂形式的口服和/或含服组合物、其制备方法以及其用途
JP2015162299A5 (https=)
CN103724709A (zh) 一种氧化普鲁兰多糖-丝胶复合物改性天然乳胶的方法
JP2017524053A (ja) エチルセルロース分散体及び粉末
JP6193425B2 (ja) 水性塗膜剥離剤
JP6110405B2 (ja) 水溶性ポリマーを分散させる非水性方法
JP5940204B1 (ja) 塗膜剥離剤
CN111246737B (zh) 用于农业应用的溶剂和农药调配物
CN110272557A (zh) 激光镂空压敏拆封拉线及其生产方法
TWI874939B (zh) 泡泡果凍膠體結構
CN105828605A (zh) 吡蚜酮配制物
JP2015536355A (ja) 水溶性ポリマーの非水性分散方法
TWI379823B (en) Aqueous n-methylolmethacrylamide/methacrylamide mixture
JP2005501160A5 (https=)
JP2016537473A5 (https=)
WO2016011596A1 (zh) 一种高稳定性、可拍打泡泡水及其制备方法